메뉴 건너뛰기




Volumn 94, Issue 5, 2009, Pages 615-617

Factor IX and deep vein thrombosis

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; VON WILLEBRAND FACTOR;

EID: 66049151298     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2009.005769     Document Type: Editorial
Times cited : (4)

References (19)
  • 1
  • 2
    • 33645456050 scopus 로고    scopus 로고
    • Can haematological tests predict cardiovascular risk? The 2005 Kettle Lecture
    • Lowe GDO. Can haematological tests predict cardiovascular risk? The 2005 Kettle Lecture. Br J Haematol 2006;133: 232-250
    • (2006) Br J Haematol , vol.133 , pp. 232-250
    • Lowe, G.D.O.1
  • 3
    • 14044254724 scopus 로고    scopus 로고
    • Elevated clotting factor levels and venous thrombosis
    • DOI 10.1159/000083835
    • Bertina RM. Elevated clotting factor levels and venous thrombosis. Pathophysiol Haemost Thromb 2003;33:395-400. (Pubitemid 40278714)
    • (2003) Pathophysiology of Haemostasis and Thrombosis , vol.33 , Issue.5-6 , pp. 395-400
    • Bertina, R.M.1
  • 4
    • 0032942943 scopus 로고    scopus 로고
    • Factor VIII, von Willebrand factor and the risk of major ischaemic heart disease in the Caerphilly Heart Study
    • DOI 10.1111/j.1365-2141.1999.01317.x
    • Rumley A, Lowe GDO, Sweetnam PM, Yarnell JWG, Ford RP. Factor VIII, von Willebrand factor and the risk of major ischaemic heart disease in the Caerphilly Study. Br J Haematol 1999;105:110-116 (Pubitemid 29197151)
    • (1999) British Journal of Haematology , vol.105 , Issue.1 , pp. 110-116
    • Rumley, A.1    Lowe, G.D.2    Sweetnam, P.M.3    Yarnell, J.W.G.4    Ford, R.P.5
  • 5
    • 0036847634 scopus 로고    scopus 로고
    • Von Willebrand factor and coronary heart disease: Prospective study and meta-analysis
    • Whincup P, Danesh J, Walker M, Lennon L, Thomson A, Appleby P, et al. Von Willebrand factor and coronary heart disease: prospective study and meta-analysis. Europ Heart J 2002;23:1764-1770
    • (2002) Europ Heart J , vol.23 , pp. 1764-1770
    • Whincup, P.1    Danesh, J.2    Walker, M.3    Lennon, L.4    Thomson, A.5    Appleby, P.6
  • 6
    • 0036908576 scopus 로고    scopus 로고
    • Coagulation factors, inflammation markers, and venous thromboembolism: The longitudinal investigation of thromboembolism etiology (LITE)
    • DOI 10.1016/S0002-9343(02)01345-1, PII S0002934302013451
    • Tsai AW, Cushman M, Rosamond WD, Heckbert SR, Tracy RP, Aleksic N, Folsom AR. Coagulation factors, inflammation markers, and venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology (LITE). Am J Med 2002;113:636-642 (Pubitemid 36015799)
    • (2002) American Journal of Medicine , vol.113 , Issue.8 , pp. 636-642
    • Tsai, A.W.1    Cushman, M.2    Rosamond, W.D.3    Heckbert, S.R.4    Tracy, R.P.5    Aleksic, N.6    Folsom, A.R.7
  • 7
    • 37549068918 scopus 로고    scopus 로고
    • ABO (H) blood groups and vascular disease: A systematic review and meta-analysis
    • Wu O, Bayoumi N, Vickers MA, Clark P. ABO (H) blood groups and vascular disease: a systematic review and meta-analysis. J Thromb Haemost 2008;6:62-69
    • (2008) J Thromb Haemost , vol.6 , pp. 62-69
    • Wu, O.1    Bayoumi, N.2    Vickers, M.A.3    Clark, P.4
  • 8
    • 0042671199 scopus 로고    scopus 로고
    • Decreased mortality of ischaemic heart disease among carriers of haemophilia
    • DOI 10.1016/S0140-6736(03)14021-4
    • Sramek A, Kriek M, Rosendaal FR. Decreased mortality of ischaemic heart disease among carriers of haemophilia. Lancet 2003;362:351-354 (Pubitemid 36945057)
    • (2003) Lancet , vol.362 , Issue.9381 , pp. 351-354
    • Sramek, A.1    Kriek, M.2    Rosendaal, F.R.3
  • 9
    • 0035669048 scopus 로고    scopus 로고
    • Factor IX and thrombosis
    • DOI 10.1046/j.1365-2141.2001.03186.x
    • Lowe GDO. Factor IX and thrombosis. Br J Haematol 2001;115:507-513 (Pubitemid 34015639)
    • (2001) British Journal of Haematology , vol.115 , Issue.3 , pp. 507-513
    • Lowe, G.D.O.1
  • 10
    • 1942436221 scopus 로고    scopus 로고
    • Mendelian randomization: Prospects, potentials, and limitations
    • DOI 10.1093/ije/dyh132
    • Davey Smith G, Ebrahim S. Mendelian randomization: prospects, potentials and limitations. Int J Epidemiol 2004; 33:30-42. (Pubitemid 38528650)
    • (2004) International Journal of Epidemiology , vol.33 , Issue.1 , pp. 30-42
    • Smith, G.D.1    Ebrahim, S.2
  • 13
    • 0034072235 scopus 로고    scopus 로고
    • Thrombotic variables and risk of idiopathic venous thromboembolism in women aged 45-64 years. Relationships to hormone replacement therapy
    • Lowe G, Woodward M, Vessey M, Rumley A, Gough P, Daly E. Thrombotic variables and risk of idiopathic venous thromboembolism in women aged 45-64 years: relationships to hormone replacement therapy. Thromb Haemost 2000;83:530-535 (Pubitemid 30201125)
    • (2000) Thrombosis and Haemostasis , vol.83 , Issue.4 , pp. 530-535
    • Lowe, G.1    Woodward, M.2    Vessey, M.3    Rumley, A.4    Gough, P.5    Daly, E.6
  • 15
    • 0030860570 scopus 로고    scopus 로고
    • Epidemiology of coagulation factors, inhibitors and activation markers: The Third Glasgow MONICA Survey. I. Illustrative reference ranges by age, sex and hormone use
    • Lowe GDO, Rumley A, Woodward M, Morrison CE, Philippou H, Lane DA, Tunstall-Pedoe H. Epidemiology of coagulation factors, inhibitors and activation markers: The Third Glasgow MONICA Survey. I. Illustrative reference ranges by age, sex and hormone use. Br J Haematol 1997; 97:775-784
    • (1997) Br J Haematol , vol.97 , pp. 775-784
    • Lowe, G.D.O.1    Rumley, A.2    Woodward, M.3    Morrison, C.E.4    Philippou, H.5    Lane, D.A.6    Tunstall-Pedoe, H.7
  • 16
    • 0030761812 scopus 로고    scopus 로고
    • Epidemiology of coagulation factors, inhibitors and activation markers: The Third Glasgow MONICA Survey. II. Relationships to cardiovascular risk factors and prevalent cardiovascular disease
    • Woodward M, Lowe GDO, Rumley A, Tunstall-Pedoe H, Philippou H, Lane DA, Morrison CE. Epidemiology of coagulation factors, inhibitors and activation markers: The Third Glasgow MONICA Survey. II. Relationships to cardiovascular risk factors and prevalent cardiovascular disease. Br J Haematol 1997;97:785-797
    • (1997) Br J Haematol , vol.97 , pp. 785-797
    • Woodward, M.1    Lowe, G.D.O.2    Rumley, A.3    Tunstall-Pedoe, H.4    Philippou, H.5    Lane, D.A.6    Morrison, C.E.7
  • 17
    • 38349093597 scopus 로고    scopus 로고
    • Relationship between markers of activated coagulation, their correlation with inflammation and association with coronary heart disease (NPHSII)
    • Miller GJ, Ireland HA, Cooper JA, Bauer KA, Morrissey JH, Humphries SE, Esnouf MP. Relationship between markers of activated coagulation, their correlation with inflammation and association with coronary heart disease (NPHSII). J Thromb Haemost 2008;6:259-267
    • (2008) J Thromb Haemost , vol.6 , pp. 259-267
    • Miller, G.J.1    Ireland, H.A.2    Cooper, J.A.3    Bauer, K.A.4    Morrissey, J.H.5    Humphries, S.E.6    Esnouf, M.P.7
  • 18
    • 54149087646 scopus 로고    scopus 로고
    • Less severe bleeding in hemophilia B than in hemophilia a
    • Lowe GD, Ludlam CA. Less severe bleeding in hemophilia B than in hemophilia A. J Thromb Haemost 2008;6:1982-1983.
    • (2008) J Thromb Haemost , vol.6 , pp. 1982-1983
    • Lowe, G.D.1    Ludlam, C.A.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.